Allied Biotech Corporation

NT$23.75As of Sun 8 Nov 2026, 12:00 UTC
TPEx:1780Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR 7.32%
Div yield 5.26%
ROE 13.72%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.20
PE TTM 12.80
TSR TTM 40.26%
Mkt cap NT$2.591B
ROIC 9.57%
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$24
1.88%
(35.01%)
Buy 9|0|7|0|1
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.33
0.34
0.35
0.37
29.86%
22.89%
18.83%
21.63%
RevenueNT$M
131.0
129.8
130.2
137.3
6.34%
0.82%
2.85%
6.53%
Peers (US$78.24M)
Cap (US$)
PE
83.10M
13.71x
Capital
TTM
5Y
10Y
Leveragex
1.720
(0.467)
(0.320)
EBIT/Intx
1.730
0.253
0.273
Own earn%
51.67
(25.84)
(27.73)
Sh yield%
55.42
34.96
34.16
Owners
Insiders/Inst%
8.50
59.63
Short interest%
2.95
SBC / revenue%
2.44
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
0–7
$1 testx
—
Incr. ROIC%
5